1000001169

NOVARTIS INDIA LIMITED

560.80
-5.15 (-0.91%) NSE

Last updated on 23 Mar 2023 5:40 PM

Returns
-1.21%
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

1396.26

Earning Per Share

-1.51

Dividend Yield

1.69%

P/E Ratio

-

P/B Ratio

1.89

Debt to Equity

0.06

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value

5.34% down side

up side5.34%


About the company

Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947. The Company is focused on manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates in four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz. The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886. In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd.

Similar Companies